Korea suspends sales of oral ketoconazole products
Published: 2013-09-16 06:58:00
Updated: 2013-09-16 06:58:00
The Ministry of Food and Drug Safety (MFDS), Korea’s health regulator, said on Thursday it would suspend sales of oral ketoconazole pills, after potentially fatal liver injury, risk of drug interactions and adrenal gland problems were linked to their use.
The ban came after the U.S. Food and D...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.